NCT01050855 - Reduced Intensity Conditioning (RIC) Regimen for Patients With Non-malignant Disorders | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions

Non Malignant DiseasesImmunodeficienciesHemoglobinopathies

Interventions

DRUG

RIC: Distal Campath

Campath, Fludarabine, Melphalan, Cyclosporine, Cellcept (MMF)

DRUG

RIC:Intermediate Campath

Campath, Fludarabine, Melphalan, Cyclosporine, Cellcept (MMF)

DRUG

RIC: Mini Busulfan

Campath, Fludarabine, Busulfan, Cyclosporine, Cellcept (MMF)

Trial Locations (1)

The Children's Hospital of Philadelphia, Philadelphia

All Listed Sponsors

lead

Children's Hospital of Philadelphia

OTHER